Applicability of Vasopressor Trials in Adult Critical Care: A Prospective Multicentre Meta-Epidemiologic Cohort Study

References

• De Backer D, Schortgen F. Physicians declining patient enrollment in clinical trials: what are the implications? Intensive Care Med. 2014;40(1):117–119. doi:10.1007/s00134-013-3151-1
   Web of Science ®Google Scholar
• Russell JA. Vasopressor therapy in critically ill patients with shock. Intensive Care Med. 2019;45(11):1503–1517. doi:10.1007/s00134-019-05801-z
   PubMed Web of Science ®Google Scholar
• Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358(9):877–887. doi:10.1056/NEJMoa067373
   PubMed Web of Science ®Google Scholar
• Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS2 tool: designing trials that are fit for purpose. Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS2 tool: designing trials that are fit for purpose. BMJ. 2015 May 8;350:h2147. doi:10.1136/bmj.h2147. PMID: 25956159.
   Web of Science ®Google Scholar
• Gamper G, Havel C, Arrich J, et al. Vasopressors for hypotensive shock. Cochrane Database Syst Rev. 2016;2:CD003709. doi:10.1002/14651858.CD003709.pub4
   PubMed Web of Science ®Google Scholar
• Albanese J, Leone M, Delmas A, Martin C. Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study. Crit Care Med. 2005;33(9):1897–1902. doi:10.1097/01.CCM.0000178182.37639.D6
   PubMed Web of Science ®Google Scholar
• Annane D, Vignon P, Renault A, et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet. 2007;370(9588):676–684. doi:10.1016/S0140-6736(07)61344-0
   PubMed Web of Science ®Google Scholar
• Boccara G, Ouattara A, Godet G, et al. Terlipressin versus norepinephrine to correct refractory arterial hypotension after general anesthesia in patients chronically treated with renin-angiotensin system inhibitors. Anesthesiology. 2003;98(6):1338–1344. doi:10.1097/00000542-200306000-00007
   Web of Science ®Google Scholar
• De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362(9):779–789. doi:10.1056/NEJMoa0907118
   PubMed Web of Science ®Google Scholar
• Dunser MW, Mayr AJ, Ulmer H, et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation. 2003;107(18):2313–2319. doi:10.1161/01.CIR.0000066692.71008.BB
   Web of Science ®Google Scholar
• Jain G, Singh DK. Comparison of phenylephrine and norepinephrine in the management of dopamine-resistant septic shock. Indian J Crit Care Med. 2010;14(1):29–34. doi:10.4103/0972-5229.63033
   Google Scholar
• Lauzier F, Levy B, Lamarre P, Lesur O. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Med. 2006;32(11):1782–1789. doi:10.1007/s00134-006-0378-0
   PubMed Web of Science ®Google Scholar
• Levy B, Bollaert PE, Charpentier C, et al. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med. 1997;23(3):282–287. doi:10.1007/s001340050329
   Web of Science ®Google Scholar
• Levy B, Perez P, Perny J, Thivilier C, Gerard A. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study. Crit Care Med. 2011;39(3):450–455. doi:10.1097/CCM.0b013e3181ffe0eb
   PubMed Web of Science ®Google Scholar
• Luckner G, Dunser MW, Stadlbauer KH, et al. Cutaneous vascular reactivity and flow motion response to vasopressin in advanced vasodilatory shock and severe postoperative multiple organ dysfunction syndrome. Crit Care. 2006;10(2):R40. doi:10.1186/cc4845
   Web of Science ®Google Scholar
• Malay MB, Ashton RC Jr, Landry DW, Townsend RN. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma. 1999;47(4):699–703;discussion 703–695. doi:10.1097/00005373-199910000-00014
   Google Scholar
• Marik PE, Mohedin M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA. 1994;272(17):1354–1357. doi:10.1001/jama.1994.03520170064037
   Web of Science ®Google Scholar
• Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest. 1993;103(6):1826–1831. doi:10.1378/chest.103.6.1826
   PubMed Web of Science ®Google Scholar
• Morelli A, Ertmer C, Lange M, et al. Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study. Br J Anaesth. 2008;100(4):494–503. doi:10.1093/bja/aen017
   PubMed Web of Science ®Google Scholar
• Morelli A, Ertmer C, Rehberg S, et al. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care. 2009;13(4):R130. doi:10.1186/cc7990
   PubMed Web of Science ®Google Scholar
• Morelli A, Ertmer C, Rehberg S, et al. Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial. Crit Care. 2008;12(6):R143. doi:10.1186/cc7121
   PubMed Web of Science ®Google Scholar
• Myburgh JA, Higgins A, Jovanovska A, et al. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med. 2008;34(12):2226–2234. doi:10.1007/s00134-008-1219-0
   PubMed Web of Science ®Google Scholar
• Patel GP, Grahe JS, Sperry M, et al. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock. Shock. 2010;33(4):375–380. doi:10.1097/SHK.0b013e3181c6ba6f
   Web of Science ®Google Scholar
• Ruokonen E, Takala J, Kari A, Saxen H, Mertsola J, Hansen EJ. Regional blood flow and oxygen transport in septic shock. Crit Care Med. 1993;21(9):1296–1303. doi:10.1097/00003246-199309000-00011
   Web of Science ®Google Scholar
• Seguin P, Bellissant E, Le Tulzo Y, et al. Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock. Clin Pharmacol Ther. 2002;71(5):381–388. doi:10.1067/mcp.2002.122471
   Web of Science ®Google Scholar
• Svoboda P, Scheer P, Kantorova I, et al. Terlipressin in the treatment of late phase catecholamine-resistant septic shock. Hepatogastroenterology. 2012;59(116):1043–1047. doi:10.5754/hge10550
   PubMedGoogle Scholar
• Seguin P, Laviolle B, Guinet P, Morel I, Malledant Y, Bellissant E. Dopexamine and norepinephrine versus epinephrine on gastric perfusion in patients with septic shock: a randomized study [NCT00134212]. Crit Care. 2006;10(1):R32. doi:10.1186/cc4827
   Web of Science ®Google Scholar
• Hua F, Wang X, Zhu L. Terlipressin decreases vascular endothelial growth factor expression and improves oxygenation in patients with acute respiratory distress syndrome and shock. J Emerg Med. 2013;44(2):434–439. doi:10.1016/j.jemermed.2012.02.073
   Web of Science ®Google Scholar
• Mathur SDR, Chakraborty A, Dhunna R. Comparison of norepinephrine and dopamine in the management of septic shock using impedance cardiography. Indian J Crit Care Med. 2007;11(4):186–191. doi:10.4103/0972-5229.37713
   Google Scholar
• Choong K, Bohn D, Fraser DD, et al. Vasopressin in pediatric vasodilatory shock: a multicenter randomized controlled trial. Am J Respir Crit Care Med. 2009;180(7):632–639. doi:10.1164/rccm.200902-0221OC
   Web of Science ®Google Scholar
• Yildizdas D, Yapicioglu H, Celik U, Sertdemir Y, Alhan E. Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children. Intensive Care Med. 2008;34(3):511–517. doi:10.1007/s00134-007-0971-x
   Web of Science ®Google Scholar
• Han XD, Sun H, Huang XY, et al. [A clinical study of pituitrin versus norepinephrine in the treatment of patients with septic shock]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012;24(1):33–37. Chinese
   Google Scholar
• PRECIS-2 Score [Homepage]. Available from: https://www.precis-2.org/. Accessed July 7, 2022.
   Google Scholar
• Ivie RM, Vail EA, Wunsch H, Goldklang MP, Fowler R, Moitra VK. Patient eligibility for randomized controlled trials in critical care medicine: an international two-center observational study. Crit Care Med. 2017;45(2):216–224. doi:10.1097/CCM.0000000000002061
   Web of Science ®Google Scholar
• Titz M, Schwameis M, Kienbacher C, et al. Generalisability of randomised trials evaluating perioperative beta-blocker therapy in noncardiac surgery. Br J Anaesth. 2020;125(6):926–934. doi:10.1016/j.bja.2020.08.006
   Web of Science ®Google Scholar
• Lanspa MJ, Morris AH. Why so few randomized trials are useful. Crit Care Med. 2017;45(2):372–373. doi:10.1097/CCM.0000000000002115
   Web of Science ®Google Scholar
• Takala J. Should we target blood pressure in sepsis? Crit Care Med. 2010;38(10 Suppl):S613–619. doi:10.1097/CCM.0b013e3181f2430c
   Web of Science ®Google Scholar
• Vincent JL, De Backer D. Circulatory shock. N Engl J Med. 2013;369(18):1726–1734. doi:10.1056/NEJMra1208943
   PubMed Web of Science ®Google Scholar
• Girbes ARJ, de Grooth HJ. Time to stop randomized and large pragmatic trials for intensive care medicine syndromes: the case of sepsis and acute respiratory distress syndrome. J Thorac Dis. 2020;12(Suppl 1):S101–S109. doi:10.21037/jtd.2019.10.36
   Web of Science ®Google Scholar
• Group RC, Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with covid-19. N Engl J Med. 2021;384(8):693–704.
   PubMed Web of Science ®Google Scholar